Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
3.000
+0.020 (0.67%)
Apr 24, 2025, 4:00 PM EDT - Market closed
Daré Bioscience Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Daré Bioscience stock have an average target of 20.33, with a low estimate of 12 and a high estimate of 36. The average target predicts an increase of 577.67% from the current stock price of 3.00.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Daré Bioscience stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +300.00% | Apr 1, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +300.00% | Dec 17, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +300.00% | Nov 15, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +300.00% | Oct 24, 2024 |
Jones Trading | Jones Trading | Strong Buy Maintains $5 → $13 | Strong Buy | Maintains | $5 → $13 | +333.33% | Aug 16, 2024 |
Financial Forecast
Revenue This Year
1.13M
from 9.78K
Increased by 11,398.36%
Revenue Next Year
21.47M
from 1.13M
Increased by 1,808.62%
EPS This Year
-2.06
from -0.48
EPS Next Year
-1.21
from -2.06
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 3.5M | 44.2M | 102.6M | ||
Avg | 1.1M | 21.5M | 71.6M | ||
Low | n/a | n/a | 41.8M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 35,396.7% | 3,829.4% | 377.7% | ||
Avg | 11,398.4% | 1,808.6% | 233.4% | ||
Low | - | - | 94.7% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -1.53 | -0.09 | 0.81 | ||
Avg | -2.06 | -1.21 | 0.49 | ||
Low | -2.43 | -2.23 | 0.20 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.